Conference preview: Life Science IP Forum, London

In an interview with Legal IQ, which is hosting the Life Science IP Forum on November 27 and 28 in London, Ryan Zurek, managing director of IP merchant bank Ocean Tomo, described the life sciences IP market as “highly inefficient”.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

AI is transforming top 100 innovators, shows index

23 January 2026 Just one pharma company is recognised in a report that lists the most world's most inventive countries and companies.

Americas

Novartis win blocks generics relitigating $7.8bn heart drug patent

22 January 2026 A district court judge shuts down a Novartis rival from reopening validity and infringement arguments over an Entresto patent.

Americas

Rooted rights: Lessons from plant patent infringement and invalidity cases

22 January 2026 From public use and foreign sales to the challenges of proving infringement, plant patents present unique legal opportunities—and pitfalls—for the agricultural industry, explain Bree Vculek, Gaby Longsworth, and Robert Millonig of Sterne Kessler.

More features

Rooted rights: Lessons from plant patent infringement and invalidity cases

How AI will be shaped by legal and regulatory developments in 2026

Key EU and UK regulatory changes to watch for in 2026

UPC: A review of 2025 and what to expect in 2026

Hogan Lovells and Cadwalader strike historic deal to create $3.6bn firm

Regeneron v Alvotech: The big impact

Beyond traditional IP: A comprehensive AI strategy for life sciences

Prosecuting bispecific antibody patents: A cookbook for patent chefs

Conference preview: Life Science IP Forum, London

More on this story

Editor's picks

Editor's picks

More features